Premier Biomedical Inc BIEI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BIEI is a good fit for your portfolio.
News
-
Premier Graphene, Inc., formerly Premier Biomedical Inc. (OTC: BIEI), announces major news in Mexico with our friends at HGI Industrial Technologies S.A de P.I and an advancement in its Graphene Enhanced Concrete
-
Premier Graphene, Inc. (BIEI) Demonstrates Industry-Leading Innovations with Graphene-Enhanced Building Materials
-
Premier Biomedical Inc. (BIEI), now known as Premier Graphene, Inc., engages Gustavo Carreño as Chief Technology Officer (CTO)
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $1.70 Mil
- Volume/Avg
- 139,844 / 1.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Premier Biomedical Inc is engaged in a hemp-based initiative, developing graphene-enhanced formulations for a myriad of commercial and military applications.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- —
- Total Number of Employees
- —
Valuation
|
Metric
|
BIEI
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
BIEI
Financial Strength
|
Metric
|
BIEI
|
|---|---|
Quick Ratio | 0.04 |
Current Ratio | 0.05 |
Interest Coverage | 0.05 |
Quick Ratio
BIEI
Profitability
|
Metric
|
BIEI
|
|---|---|
Return on Assets (Normalized) | −472.19% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BIEI
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Xvkncbzkw | Hcsym | $79.1 Bil | |
MKKGY
| Merck KGaA ADR | Chvfcvrjh | Mpfyq | $74.3 Bil | |
HLN
| Haleon PLC ADR | Msvqlzk | Kxzy | $37.6 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Vshrxvpc | Pghyq | $19.1 Bil | |
VTRS
| Viatris Inc | Stzyllcj | Xdwyw | $13.2 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Kfvsfmmb | Bwp | $11.7 Bil | |
CTLT
| Catalent Inc | Qsznqxlpp | Lkcby | $10.0 Bil | |
CURLF
| Curaleaf Holdings Inc | Gwbdjyfq | Zgy | $4.2 Bil | |
PRGO
| Perrigo Co PLC | Krtkmxd | Msgz | $4.1 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Nrvynddvd | Bqhvrm | $3.3 Bil |